Results 11 to 20 of about 14,549 (184)
The Diagnostic and Clinical Utility of Autoantibodies in Systemic Vasculitis
Considerable progress has been made in understanding the role of autoantibodies in systemic vasculitides (SV), and consequently testing for anti-neutrophil cytoplasmic antibodies (ANCA), anti-glomerular basement membrane antibodies (anti-GBM), and anti ...
Elena Csernok
doaj +1 more source
Introduction Anti-neutrophilic cytoplasmic antibody (ANCA) has been reported in systemic sclerosis (SSc). Some clinical features of SSc can also be presented with ANCA-associated vasculitis.
Ajanee Mahakkanukrauh +3 more
doaj +1 more source
ANCA-associated vasculitis overlaps with systemic sclerosis: a case report and literature review
Background Systemic sclerosis (SSc) and anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) both affect the kidney and may cause renal failure. Treatment of AAV is dramatically different from that of SSc renal crisis (SRC).
Rui Wu, Jiang Su, Yu-rong Zou, Jing Zhu
doaj +1 more source
ANCA Associated Vasculitis Treated with Ultra-low Dose Rituximab: A Case Report
We reported a case of ANCA-associated vasculitis with pulmonary and renal involvement that was effectively treated with glucocorticoids, cyclophosphamide, and plasma exchange therapy.
WU Haiting, LI Hang
doaj +1 more source
Characterizing infection in anti-neutrophil cytoplasmic antibody-associated vasculitis:results from a longitudinal, matched-cohort data linkage study [PDF]
Objectives: Infection exerts a major burden in ANCA-associated vasculitis (AAV), however, its precise extent and nature remains unclear. In this national study we aimed to longitudinally quantify, characterize and contextualize infection risk in AAV ...
Amft, Nicole +11 more
core +6 more sources
Checkpoint inhibitor-related renal vasculitis and use of rituximab
The percentage of patients with cancer eligible for checkpoint inhibitor (CPI) therapy has increased rapidly over the past few years and approaches 45%.
Noha Abdel-Wahab +6 more
doaj +1 more source
Incidence of ANCA-associated vasculitis in a UK mixed ethnicity population [PDF]
Objectives: We aimed to estimate the incidence of ANCA-associated vasculitis in the UK and how this varied by ethnic group. Methods: We identified incident cases of ANCA-associated vasculitis between March 2007 and June 2013 in the Nottingham–Derby ...
Alfred Mahr +10 more
core +1 more source
Cryoglobulinaemic vasculitis: classification and clinical and therapeutic aspects [PDF]
Cryoglobulinaemia may cause cutaneous vasculitis and glomerulonephritis, potentially leading to end stage renal failure. An important proportion of cryoglobulinaemias are secondary to hepatitis C virus infection.
Braun, Gerald S. +4 more
core +2 more sources
Clinic manifestations in granulomatosis with polyangiitis [PDF]
Granulomatosis with polyangiitis (GPA), formerly Wegener's granulomatosis (WG), is an uncommon immunologically mediated systemic small-vessel vasculitis that is pathologically characterised by an inflammatory reaction pattern (necrosis, granulomatous ...
De Vincentiis, Marco +7 more
core +1 more source
Background/Purpose: A reliable noninvasive prognostic factor of ANCA-associated vasculitis (AAV) is still lacking, but little research has focused on the value of MPO-ANCA titers in patients with active vasculitis.
Chieh-Li Yen +8 more
doaj +1 more source

